FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Roche Companion Diagnostic for AbbVies Emrelis OKd

FDA approves Roches Ventana MET (SP44) RxDx Assay, a companion diagnostic to aid in determining MET protein expression in lung cancer patients to dete...

latest-news-card-1
Medical Devices

Nipro Renal Recalls MedicaLyte Hemodialysis Product

Nipro Renal Soultions recalls (Class 1) its MedicaLyte Liquid Bicarbonate Concentrate due to the potential for the presence of visible foreign matter ...

latest-news-card-1
Human Drugs

Agency Has Evolved in the Last 10 Years: Verdun

CBERs Nicole Verdun tells a Friends of Cancer Research meeting on next-generation therapies that FDA has evolved in the last decade in its ability to ...

latest-news-card-1
Biologics

Makary Says Vaccine Framework Coming Soon

FDA commissioner Marty Makary says the agency is planning to release in the coming days a vaccine development framework to help with predictability fo...

latest-news-card-1
Human Drugs

Malaysias BioAsia Worldwide CGMP Issues

FDA warns Malaysias BioAsia Worldwide about CGMP violations in its production of finished drugs, some of which may be regulated as cosmetics.

latest-news-card-1
Human Drugs

Cytokinetics Reports Exercise Data on Heart Drug

Cytokinetics reports topline results from its Phase 3 MAPLE-HCM clinical trial showing that aficamten significantly improved exercise capacity in pati...

latest-news-card-1
Human Drugs

Hunter Syndrome Gene Therapy Accepted for Review

FDA accepts for priority review a Regenxbio BLA seeking accelerated approval for gene therapy RGX-121 (clemidsogene lanparvovec) for treating Hunter s...

latest-news-card-1
Human Drugs

CGMP Violations at Chinas Shantou S.E.Z. Baojie

FDA warns Chinas Shantou S.E.Z. Baojie Industry about CGMP violations in its production of finished drugs, some of which may be regulated as cosmetics...

latest-news-card-1
Human Drugs

FDA Doubts May Move Trials Overseas: Report

Biotech executives, investors, and consultants say some companies are moving early clinical trials overseas due to fears of instability and slowness a...

latest-news-card-1
Human Drugs

FDA OKs First Oral Therapy for Rare Adrenal Tumors

FDA approves a Merck NDA for Welireg (belzutifan), an oral drug for treating adults and pediatric patients aged 12 and older with locally advanced, un...